Drug Profile
VTC 064
Alternative Names: VTC-064Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Virtici
- Class Recombinant fusion proteins
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Peanut hypersensitivity
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Peanut-hypersensitivity in USA (PO)
- 12 Aug 2016 Early research in Peanut hypersensitivity in USA (PO)